News

A number of stocks fell in the afternoon session after rising Treasury yields and higher interest rates intensified worries over household finances and discretionary consumption, creating headwind conditions for consumer-facing companies. According to Reuters, as borrowing costs on mortgages, auto loans, and credit cards climb, household budgets are increasingly squeezed, encouraging consumers to prioritize saving and basic necessities over non-essential purchases. In addition, recent economic d

Cybersecurity and related companies were hot with investors this week, on gloomy predictions about the future of AI.

The streaming giant just bought back more stock in a single quarter than ever before. But is that a reason to own it?

David Einhorn believes this probably may extend beyond SpaceX.

The rig count in the Permian Basin was up one this week, the latest count Friday by Baker Hughes shows, with 269 rigs active in the region. A year ago, 254 rigs were active in the region. Nationally, the oil and gas rig count is up four from last week at 595 rigs. A year ago, 542 rigs were active. The count shows that 452 rigs sought oil, up two from the previous week, and 134 explored for ...

A number of stocks fell in the afternoon session after markets remained volatile during the last trading session of the week, reflecting growing uncertainty, with the broad market retreat erasing the sector's gains from the previous day.

It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company.

REVIEW PREVIEW NEWSLETTER Spooky Season. The Dow Jones Industrial Average really needs to shake off this bad juju. The blue-chip index fell 122 points, or 0.2%, on Friday, wrapping up its worst week since March, according to Dow Jones Market Data.

Sept 18 (Reuters) - Withdrawal requests at a Morgan Stanley private credit fund remained elevated in the third-quarter repurchase offer, according to a regulatory filing on Friday, as the investment

Investing.com -- NASA and Boeing are discussing using the Starliner spacecraft for 10 or more new missions to low-Earth orbit, despite technical failures during its troubled 2024 crewed test flight, the Wall Street Journal reported exclusively.

Shares of materials and photonics company Coherent (NYSE:COHR) jumped 4.1% in the afternoon session after the company announced the expansion of its Pluggable Optical Line System portfolio designed to support artificial intelligence datacenter networks. According to a company press release, the expanded Pluggable Optical Line System portfolio features a full C-band, high-power variable-gain amplifier in a compact QSFP form factor. Designed for 800G ZR and ZR+ digital coherent optics, the hardwar

A simple momentum screen applied to S&P 500 stocks has quietly built a performance gap that turns identical starting portfolios into dramatically different ending balances, and the strategy costs almost nothing to implement.

The specialty retailer reported a notable insider stock disposition through indirect entities, including a family foundation.

Restaurants are struggling with higher prices for ingredients and labor, as well as the wellness trend the need for innovation:

A number of stocks fell in the afternoon session after markets remained volatile during the last trading session of the week, reflecting growing uncertainty, with the broad market retreat erasing the sector's gains from the previous day. As detailed by CNBC, major market averages initially dropped on Wednesday following the Federal Reserve's first interest rate hike in three years, then staged a strong tech-led comeback on Thursday, before falling once more. According to market commentators, aft

An interest rate hike amid soaring energy costs and rising inflation concerns has weighed on the Dow.

Bitwise CIO Matt Hougan reversed a months-long warning about the CLARITY Act within 24 hours of its Senate defeat, and the market celebrated his pivot. But three quiet caveats buried in his memo tell a different story about what he actually believes.

Wall Street analysts are turning more bullish on AI infrastructure names after the summer selloff, with IREN and Cipher Digital receiving higher price targets tied to contract growth, power availability…

A number of stocks fell in the afternoon session after markets remained volatile during the last trading session of the week, reflecting growing uncertainty, with the broad market retreat erasing the sector's gains from the previous day.

In SEC filings for a $2.2B debt raise, CleanSpark revealed that Meta holds the lease for its $6.6B deal at Sandersville, plus exclusivity rights for 885 MW in Texas.

Cybersecurity provider CrowdStrike Holdings, Inc. (NASDAQ:CRWD)’s shares are up by more than 100% year to date. With AI continuing to dominate the market narrative, the firm has found itself at the center of the industry’s concerns about cybersecurity. While some, such as Anthropic’s Dario Amodei, have claimed that their AI software is sufficient for cybersecurity […]

GE Vernova Inc. (NYSE:GEV) is one of Jim Cramer’s favorite stocks. Throughout 2025, the CNBC TV host continued to heap praise on the firm. Cramer’s praise came at a time when new-age nuclear power and quantum computing stocks were experiencing strong gains. Throughout this period, he continued to assert that GE Vernova Inc. (NYSE:GEV) was […]

For custom chip designer Broadcom Inc. (NASDAQ:AVGO), the debate is all about whether the demand for AI products will sustain and grow. It is among the few firms capable of designing custom AI chips that big technology firms rely on to supplement NVIDIA’s high-power and expensive AI chips. Anthropic CEO Dario Amodei’s latest remarks about […]

A number of stocks fell in the afternoon session after markets remained volatile during the last trading session of the week, reflecting growing uncertainty, with the broad market retreat erasing the sector's gains from the previous day.

Walmart Inc. (NASDAQ:WMT)’s shares closed higher between September 11th and September 14th. On the 11th, before market open, grocery firm The Kroger Co. (NYSE:KR) had reported its second quarter earnings, following which the stock closed 2.7% higher. Cramer has discussed Walmart Inc. (NASDAQ:WMT) several times over the past couple of months. In particular, the CNBC […]

Oil refiner Valero Energy Corporation (NYSE:VLO)’s shares are up by more than 140% over the past year. It is among the handful of oil stocks that have benefited due to the ongoing tensions in the Middle East. Valero Energy Corporation (NYSE:VLO)’s refining operations mean that as long as it is guaranteed a steady supply of crude […]

Oil giant Chevron Corporation (NYSE:CVX) is one of Cramer’s top stocks in the space as he has repeatedly praised the firm for more than a year. While his earlier remarks about the company focused on factors such as its dividend and operational presence, more recently, Cramer has also started to discuss Chevron Corporation (NYSE:CVX) CEO […]

Costco Wholesale Corporation (NASDAQ:COST) has started to regularly feature on Jim Cramer’s watchful radar lately. The reason is clear as the shares are down by more than 18% since their peak in May. For Cramer, the share price movement is important since not only is Costco Wholesale Corporation (NASDAQ:COST) a part of his charitable trust […]

Glass technology products manufacturer Corning Incorporated (NYSE:GLW) has had an interesting relationship with Jim Cramer’s radar. Late last year, the CNBC TV host was one of the firm’s strongest supporters as he praised it for its partnership with Apple to bring manufacturing back to the US under President Trump’s initiatives. However, more recently, he has […]

Merck (NYSE:MRK) received a positive opinion from the EMA’s CHMP for KEYTRUDA plus Padcev in muscle-invasive bladder cancer. The CHMP backed the combination as perioperative therapy for adults with resectable muscle-invasive bladder cancer in the European Union. If endorsed by the European Commission, the regimen would be the first PD-1 inhibitor plus antibody-drug conjugate option for this setting in Europe. The CHMP verdict on KEYTRUDA plus Padcev is only one piece of the wider Merck story...